PEAK6
LLY icon

PEAK6’s Eli Lilly LLY Stock Holding History

PEAK6’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$170M Sell
146,800
-2,600
-2% -$3.07M 0.31% 62
2026
Q2 		$179M Sell
149,400
-1,100
-0.7% -$1.12M 0.37% 52
2026
Q1 		$138M Sell
150,500
-172,300
-53% -$175M 0.32% 55
2025
Q4 		$347M Buy
322,800
+51,500
+19% +$49.2M 0.65% 34
2025
Q3 		$207M Buy
271,300
+79,600
+42% +$59.2M 0.3% 66
2025
Q2 		$149M Buy
191,700
+25,200
+15% +$19.6M 0.28% 72
2025
Q1 		$138M Sell
166,500
-105,200
-39% -$87.5M 0.31% 68
2024
Q4 		$210M Buy
+271,700
New +$225M 0.44% 44

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

PEAK6's LLY Position: Q3 2026 in Review

PEAK6 held its Eli Lilly (LLY) position steady in Q3 2026 at 1 share worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2495.

PEAK6 first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $15.7M in Q1 2025. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • PEAK6 held 1 share of Eli Lilly worth $1.18K as of Q3 2026.
  • PEAK6 left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #2495 holding.
  • PEAK6 first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • PEAK6's Eli Lilly position peaked at $15.7M in Q1 2025.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.